SEC Form 4 · accession 0001209191-16-109823
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Lindemoen
Officer — SVP Sales and Client Services
Period of report
Mar 17, 2016
Accepted (ET)
Mar 21, 2016 · 6:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Mar 17, 2016 | A | 7,029 | $0.00 | A | 23,186 | D | |
| Common Stock, $0.01 par value | Mar 17, 2016 | F | 3,516 | $19.99 | D | 19,670 | D | |
| Common Stock, $0.01 par value | Mar 17, 2016 | A | 6,253 | $0.00 | A | 25,923 | D |
Table II — derivative securities
No Table II lines on this filing.